Serum collagen type VI and XIV and hyaluronic acid as early indicators for altered connective tissue turnover in alcoholic liver disease

被引:47
作者
Stickel, F
Urbaschek, R
Schuppan, D
Poeschl, G
Oesterling, C
Conradt, C
McCuskey, RS
Simanowski, UA
Seitz, HK [1 ]
机构
[1] Salem Med Ctr, Lab Alcohol Res Liver Dis & Nutr, D-69121 Heidelberg, Germany
[2] Salem Med Ctr, Dept Med, D-69121 Heidelberg, Germany
[3] Univ Erlangen Nurnberg, Dept Med 1, Erlangen, Germany
[4] Heidelberg Univ, Dept Med, D-6800 Mannheim, Germany
[5] Heidelberg Univ, Dept Microbiol & Hyg, D-6800 Mannheim, Germany
[6] Free Univ Berlin, Benjamin Franklin Hosp, Dept Gastroenterol, D-1000 Berlin, Germany
[7] Heidelberg Univ, Dept Med Biometry, Heidelberg, Germany
[8] Univ Arizona, Coll Med, Dept Cell Biol & Anat, Tucson, AZ USA
关键词
liver fibrosis; alcohol; collagen VI; collagen XIV; hyaluronic acid; transforming growth factor-beta(1);
D O I
10.1023/A:1010616021659
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Hepatic fibrosis in alcoholic liver disease often heralds progression to cirrhosis and, therefore, noninvasive parameters are required for early diagnosis and follow-up. Collagens VI and XIV, procollagen-III-N-propeptide, hyaluronic acid, and active transforming growth factor-beta (1) (TGF-beta (1)) were measured in healthy volunteers, patients with alcoholic cirrhosis, and heavy drinkers without cirrhosis. Noncirrhotic alcoholics were assigned to two groups with either normal aspartate aminotransferase or levels greater than or equal to2 normal. Collagens VI and XIV were elevated in all alcoholic patients compared to controls (P < 0.0001, all instances). Procollagen-III-N-propeptide and hyaluronic acid levels were higher in alcoholic patients with elevated liver enzymes and in cirrhotics as compared to controls. Procollagen-III-N-propeptide revealed a significant correlation with serum levels of TGF-<beta>(1) (P < 0.0001). Collagens VI, and XIV, procollagen-III-N-propeptide, and hyaluronic acid appear to be sensitive markers indicating fibrotic transformation in alcoholics. The correlation between procollagen-III-N-propeptide and TGF-<beta>(1) emphasizes its role in hepatic fibrogenesis.
引用
收藏
页码:2025 / 2032
页数:8
相关论文
共 44 条
[1]   INCREASED TRANSFORMING GROWTH FACTOR-BETA-1 GENE-EXPRESSION IN HUMAN LIVER-DISEASE [J].
ANNONI, G ;
WEINER, FR ;
ZERN, MA .
JOURNAL OF HEPATOLOGY, 1992, 14 (2-3) :259-264
[2]   SERUM TYPE-III PROCOLLAGEN PEPTIDE AND LAMININ (LAM-P1) DETECT ALCOHOLIC HEPATITIS IN CHRONIC ALCOHOL ABUSERS [J].
ANNONI, G ;
COLOMBO, M ;
CANTALUPPI, MC ;
KHLAT, B ;
LAMPERTICO, P ;
ROJKIND, M .
HEPATOLOGY, 1989, 9 (05) :693-697
[3]   TRANSFORMING GROWTH-FACTOR-BETA AS A PREDICTOR OF LIVER AND LUNG FIBROSIS AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR ADVANCED BREAST-CANCER [J].
ANSCHER, MS ;
PETERS, WP ;
REISENBICHLER, H ;
PETROS, WP ;
JIRTLE, RL .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (22) :1592-1598
[4]  
BEDOSSA P, 1995, J HEPATOL, V22, P37
[5]   CONNECTIVE-TISSUE BIOLOGY AND HEPATIC-FIBROSIS - REPORT OF A CONFERENCE [J].
BISSELL, DM ;
FRIEDMAN, SL ;
MAHER, JJ ;
ROLL, FJ .
HEPATOLOGY, 1990, 11 (03) :488-498
[6]   Silymarin retards collagen accumulation in early and advanced biliary fibrosis secondary to complete bile duct obliteration in rats [J].
Boigk, G ;
Stroedter, L ;
Herbst, H ;
Waldschmidt, J ;
Riecken, EO ;
Schuppan, D .
HEPATOLOGY, 1997, 26 (03) :643-649
[7]  
BORDER WA, 1994, NEW ENGL J MED, V331, P1286
[8]   REGULATION OF UNDULIN SYNTHESIS AND GENE-EXPRESSION IN HUMAN FAT-STORING CELLS BY ACETALDEHYDE AND TRANSFORMING GROWTH-FACTOR-BETA-1 - COMPARISON WITH FIBRONECTIN [J].
CASINI, A ;
CENI, E ;
SALZANO, R ;
SCHUPPAN, D ;
MILANI, S ;
PELLEGRINI, G ;
SURRENTI, C .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 199 (02) :1019-1026
[9]   REGULATION OF EXTRACELLULAR-MATRIX SYNTHESIS BY TRANSFORMING GROWTH FACTOR-BETA(1) IN HUMAN FAT-STORING CELLS [J].
CASINI, A ;
PINZANI, M ;
MILANI, S ;
GRAPPONE, C ;
GALLI, G ;
JEZEQUEL, AM ;
SCHUPPAN, D ;
ROTELLA, CM ;
SURRENTI, C .
GASTROENTEROLOGY, 1993, 105 (01) :245-253
[10]   TRANSFORMING GROWTH FACTOR-BETA-1 AND FACTOR-ALPHA IN CHRONIC LIVER-DISEASE - EFFECTS OF INTERFERON ALFA THERAPY [J].
CASTILLA, A ;
PRIETO, J ;
FAUSTO, N .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (14) :933-940